Gil Schwartzberg

2021

In 2021, Gil Schwartzberg earned a total compensation of $1.1M as Director at LIXTE BIOTECHNOLOGY HOLDINGS.

Compensation breakdown

Option Awards$1,037,830
Other$14,556
Total$1,052,386

Schwartzberg received $1M in option awards, accounting for 99% of the total pay in 2021.

Schwartzberg also received $14.6K in other compensation.

Rankings

In 2021, Gil Schwartzberg's compensation ranked 8,632nd out of 12,415 executives tracked by ExecPay. In other words, Schwartzberg earned more than 30.5% of executives.

ClassificationRankingPercentile
All
8,632
out of 12,415
31st
Division
Manufacturing
3,829
out of 5,505
30th
Major group
Chemicals And Allied Products
1,694
out of 2,375
29th
Industry group
Drugs
1,507
out of 2,096
28th
Industry
Pharmaceutical Preparations
1,123
out of 1,546
27th
Source: SEC filing on November 4, 2024.

Schwartzberg's colleagues

We found five more compensation records of executives who worked with Gil Schwartzberg at LIXTE BIOTECHNOLOGY HOLDINGS in 2021.

2021

Regina Brown

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Yun Yen

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Philip Palmedo

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Stephen Forman

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Winson Ho

LIXTE BIOTECHNOLOGY HOLDINGS

Director

In-depth

You may also like